Position
Chief Medical Officer
Company
Novocure
ZugBiotechnologyHealth CareMedicalTherapeuticsDescription
Novocure today announced the appointment of Nicolas Leupin to the role of Chief Medical Officer. Dr. Leupin brings a proven track record of leadership and accomplishment in the biotechnology and pharmaceutical industries, as well as extensive experience as a medical oncologist and educator.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D., as Chief Executive Officer and Expands Leadership Team (January 4, 2024)
- Immunome, Inc. Announces Chief Financial Officer Changes, Effective January 2, 2024 (December 30, 2023)
- Compugen Welcomes Kara Rudy as Vice President, Marketing (January 22, 2024)
- Mirai Medical Welcomes Former Boston Scientific Executive, David A. Pierce, as Non-Executive Director (January 23, 2024)
- TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer (January 29, 2024)
- Corcept Appoints Roberto Vieira as President, Oncology (January 29, 2024)
Who to call at Novocure, and when
A new leader at Novocure brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Novocure raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novocure, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novocure. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novocure changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Novocure changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.